McGill University Lady Davis Institute for Medical Research — Jewish General Hospital The ReSPCT Guidelines Reporting of Setting in Psychedelic Clinical Trials

Contact

Contact Us

Any questions? Feel free to get in touch.

Write to any of the authors of the ReSPCT Delphi consensus. Questions about the guidelines, requests to reuse the materials and reports of errors are all welcome.

Chloé Pronovost-Morgan

First author, ReSPCT Delphi study
McGill University

chloe.pronovost-morgan@mail.mcgill.ca

Kyle T. Greenway

Senior author, Psychedelics & Contemplation Lab
McGill University · Lady Davis Institute, Jewish General Hospital

kyle.greenway@mcgill.ca

Leor Roseman

Senior author
University of Exeter

l.roseman@exeter.ac.uk

Reference: Pronovost-Morgan C, Greenway KT, Roseman L & The ReSPCT Experts. An international Delphi consensus for reporting of setting in psychedelic clinical trials. Nature Medicine. 2025. https://www.nature.com/articles/s41591-025-03685-9 (doi:10.1038/s41591-025-03685-9)